au.\*:("VERNON, Andrew")
Results 1 to 16 of 16
Selection :
Effects of rifampin and multidrug resistance gene polymorphism on concentrations of MoxifloxacinWEINER, Marc; BURMAN, William; LUO, Chi-Cheng et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 8, pp 2861-2866, issn 0066-4804, 6 p.Article
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapyWEINER, Marc; BOCK, Naomi; GOLDBERG, Stefan et al.American journal of respiratory and critical care medicine. 2004, Vol 169, Num 11, pp 1191-1197, issn 1073-449X, 7 p.Article
Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials ConsortiumDORMAN, Susan E; GOLDBERG, Stefan; NARITA, Masahiro et al.The Journal of infectious diseases. 2012, Vol 206, Num 7, pp 1030-1040, issn 0022-1899, 11 p.Article
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adultsJOHNSON, John L; OKWERA, Alphonse; VERNON, Andrew et al.AIDS (London). 2001, Vol 15, Num 16, pp 2137-2147, issn 0269-9370Article
Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary TuberculosisDORMAN, Susan E; JOHNSON, John L; GUY, Elizabeth et al.American journal of respiratory and critical care medicine. 2009, Vol 180, Num 3, pp 273-280, issn 1073-449X, 8 p.Article
Factors associated with loss to follow-up in a large tuberculosis treatment trial (TBTC study 22)SEPULVEDA CONWELL, Donna; MOSHER, Ann; KHAN, Awal et al.Contemporary clinical trials. 2007, Vol 28, Num 3, pp 288-294, issn 1551-7144, 7 p.Article
Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentineWEINER, Marc; BURMAN, William; VERNON, Andrew et al.American journal of respiratory and critical care medicine. 2003, Vol 167, Num 10, pp 1341-1347, issn 1073-449X, 7 p.Article
Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosisBURMAN, William; BENATOR, Debra; WEINER, Marc et al.American journal of respiratory and critical care medicine. 2006, Vol 173, Num 3, pp 350-356, issn 1073-449X, 7 p.Article
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosisBURMAN, William J; GOLDBERG, Stefan; VERNON, Andrew et al.American journal of respiratory and critical care medicine. 2006, Vol 174, Num 3, pp 331-338, issn 1073-449X, 8 p.Article
Quality assurance in a large clinical trials consortium : The experience of the Tuberculosis Trials ConsortiumSANDMAN, Laurie; MOSHER, Ann; KHAN, Awal et al.Contemporary clinical trials. 2006, Vol 27, Num 6, pp 554-560, issn 1551-7144, 7 p.Article
Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosisWEINER, Marc; SENATOR, Debra; PELOQUIN, Charles A et al.Clinical infectious diseases. 2005, Vol 41, Num 9, pp 1343-1349, issn 1058-4838, 7 p.Article
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in miceLOUNIS, Nacer; BENTOUCHA, Abdelhalim; TRUFFOT-PERNOT, Chantal et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 12, pp 3482-3486, issn 0066-4804Article
Deployment challenges for access/metro optical networks and servicesWRIGHT, Steven; FAHMY, Hany; VERNON, Andrew J et al.Journal of lightwave technology. 2004, Vol 22, Num 11, pp 2606-2616, issn 0733-8724, 11 p.Article
Recent transmission of tuberculosis in Madrid: application of capture-recapture analysis to conventional and molecular epidemiology. Commentary : Infectious diseasesINIGO, J; ARCE, A; MARTIN-MORENO, J. M et al.International journal of epidemiology. 2003, Vol 32, Num 5, pp 763-771, issn 0300-5771, 9 p.Article
Potent twice-weekly rifapentine-containing regimens in murine tuberculosisROSENTHAL, Ian M; WILLIAMS, Kathy; TYAGI, Sandeep et al.American journal of respiratory and critical care medicine. 2006, Vol 174, Num 1, pp 94-101, issn 1073-449X, 8 p.Article
Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infectionBENATOR, Debra A; WEINER, Marc H; HSYU, Poe H et al.Pharmacotherapy. 2007, Vol 27, Num 6, pp 793-800, issn 0277-0008, 8 p.Article